Lineage Cell Therapeutics stock price
NYSEAMERICAN:LCTX · NYSE Amex · Healthcare · sector #16Lineage Cell Therapeutics's chart data is dated 2026-10-21. There is no active technical signal. The display ticker is LCTX.
Lineage Cell Therapeutics last closed at $0.9515 (-2.17%) on 2026-10-21. Listed on NYSE Amex. Trailing 12 months PER is -7.7×. Its overall grade ranks 416 of 727 stocks in Healthcare.
About this company
Lineage Cell Therapeutics last closed at $0.9515 (-2.17%) on 2026-10-21. Listed on NYSE Amex.
Details →Reported results
Position in sector
Healthcare · Overall B- · 416/727
Valuation grade B+
Related stocks
- Astellas PharmaCustomer
- Ginkgo Bioworks Holdings Class ACustomer
- Fate TherapeuticsCompetitor
About Lineage Cell Therapeutics
- What technical signals does Lineage Cell Therapeutics (LCTX) have?
- Lineage Cell Therapeutics current technical signals: no active technical signal.
- Is Lineage Cell Therapeutics a cup-and-handle pattern?
- No. Lineage Cell Therapeutics has no valid Cup signal right now.
- What published figures are available for Lineage Cell Therapeutics?
- Market cap: $219.16M. Trailing 12 months PER: -7.7×. Latest quarter PBR: 4.16×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-22 dataset
Turn what you saw on this name into a strategy
Ask Q about Lineage Cell Therapeutics, or open the plan table on the main site.
Ask Q about Lineage Cell Therapeutics.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.